Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Sciadonic acid modulates prostaglandin E2 production by epithelial cells during infection with C. albicans and C. dubliniensis.

Ells R, Kock JL, Albertyn J, Hugo A, Pohl CH.

Prostaglandins Other Lipid Mediat. 2012 Jan;97(1-2):66-71. doi: 10.1016/j.prostaglandins.2011.12.001. Epub 2011 Dec 10.

PMID:
22178003
2.

Phospholipid Incorporation of Non-Methylene-Interrupted Fatty Acids (NMIFA) in Murine Microglial BV-2 Cells Reduces Pro-Inflammatory Mediator Production.

Chen SJ, Chuang LT, Liao JS, Huang WC, Lin HH.

Inflammation. 2015 Dec;38(6):2133-45. doi: 10.1007/s10753-015-0196-z.

PMID:
26111478
3.

Involvement of aspirin-sensitive oxylipins in vulvovaginal candidiasis.

Deva R, Ciccoli R, Kock L, Nigam S.

FEMS Microbiol Lett. 2001 Apr 20;198(1):37-43.

4.

Effect of fatty acid modification on prostaglandin production by cultured 3T3 cells.

Denning GM, Figard PH, Spector AA.

J Lipid Res. 1982 May;23(4):584-96.

5.

Characterization of prostaglandin E2 production by Candida albicans.

Erb-Downward JR, Noverr MC.

Infect Immun. 2007 Jul;75(7):3498-505. Epub 2007 Apr 30.

6.

Effect of inhibitors of arachidonic acid metabolism on prostaglandin E₂ production by Candida albicans and Candida dubliniensis biofilms.

Ells R, Kock JL, Albertyn J, Kemp G, Pohl CH.

Med Microbiol Immunol. 2011 Feb;200(1):23-8. doi: 10.1007/s00430-010-0169-7. Epub 2010 Sep 7.

PMID:
20821232
7.

Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans.

Stokes C, Moran GP, Spiering MJ, Cole GT, Coleman DC, Sullivan DJ.

Fungal Genet Biol. 2007 Sep;44(9):920-31. Epub 2007 Jan 23.

PMID:
17251042
9.

Differential regulation of the transcriptional repressor NRG1 accounts for altered host-cell interactions in Candida albicans and Candida dubliniensis.

Moran GP, MacCallum DM, Spiering MJ, Coleman DC, Sullivan DJ.

Mol Microbiol. 2007 Nov;66(4):915-29. Epub 2007 Oct 10.

10.

Adherence of different Candida dubliniensis isolates in the presence of fluconazole.

Borg-von Zepelin M, Niederhaus T, Gross U, Seibold M, Monod M, Tintelnot K.

AIDS. 2002 Jun 14;16(9):1237-44.

PMID:
12045488
13.

Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale.

Calder PC.

Biochimie. 2009 Jun;91(6):791-5. doi: 10.1016/j.biochi.2009.01.008. Review.

PMID:
19455748
14.
15.

In vitro mechanisms of interleukin-8-mediated responses of human gingival epithelial cells to Candida albicans infection.

Egusa H, Nikawa H, Makihira S, Yatani H, Hamada T.

Int J Med Microbiol. 2006 Aug;296(4-5):301-11. Epub 2006 Mar 20.

PMID:
16545602
16.

Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism.

Santoli D, Zurier RB.

J Immunol. 1989 Aug 15;143(4):1303-9. Erratum in: J Immunol 1990 Jan 15;144(2):774.

PMID:
2545787
17.

LAAE-14, a new anti-inflammatory drug, increases the survival of Candida albicans-inoculated mice.

Lucas R, Villamón E, Payá M, Alves M, del Olmo E, Gozalbo D, Gil ML.

FEMS Immunol Med Microbiol. 2004 Apr 9;40(3):239-42.

18.
19.

Pathogenic yeasts Cryptococcus neoformans and Candida albicans produce immunomodulatory prostaglandins.

Noverr MC, Phare SM, Toews GB, Coffey MJ, Huffnagle GB.

Infect Immun. 2001 May;69(5):2957-63.

20.

Effects of IgY against Candida albicans and Candida spp. Adherence and Biofilm Formation.

Fujibayashi T, Nakamura M, Tominaga A, Satoh N, Kawarai T, Narisawa N, Shinozuka O, Watanabe H, Yamazaki T, Senpuku H.

Jpn J Infect Dis. 2009 Sep;62(5):337-42.

Supplemental Content

Support Center